Amy Turner
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Molecular Biology top 10%
- Cell death mechanisms and regulation
- Muscle Physiology and Disorders
- Protein Kinase Regulation and GTPase Signaling
- RNA modifications and cancer
Papers in
-
- RNA Research and Splicing 4
- Retinoids in leukemia and cellular processes 4
- RNA modifications and cancer 4
- Muscle Physiology and Disorders 4
- Pharmacology 14
- Pharmacogenetics and Drug Metabolism 14
- Co-authors
- W. David Jarvis (6 shared papers)Steven Grant (6 shared papers)Rebecca S. Traylor (3 shared papers)Lawrence F. Povirk (2 shared papers)Ulrich Broeckel (21 shared papers)Praful Aggarwal (13 shared papers)Andrea Gaedigk (14 shared papers)Kevin P. Campbell (3 shared papers)
- Journals
- Journal of Molecular Diagnostics (9 papers)Clinical Pharmacology & Therapeutics (3 papers)Journal of Neuroscience (2 papers)Biochemical Pharmacology (2 papers)Frontiers in Genetics (2 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Amy Turner
42 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 105
- Pharmacology 341
- Molecular Biology 1.1k
- Transplantation 27
- Cancer Research 148
- Oncology 268
Countries citing papers authored by Amy Turner
This map shows the geographic impact of Amy Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Turner more than expected).
Fields of papers citing papers by Amy Turner
This network shows the impact of papers produced by Amy Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Turner. The network helps show where Amy Turner may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Turner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. | 1994 | 328 |
| 2 | 2019 | 158 | |
| 3 | 2015 | 107 | |
| 4 | 2010 | 104 | |
| 5 | Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA. | 1992 | 84 |
| 6 | 1994 | 81 | |
| 7 | 2012 | 74 | |
| 8 | 2015 | 70 | |
| 9 | 2009 | 70 | |
| 10 | 2008 | 62 | |
| 11 | 2009 | 61 | |
| 12 | 2019 | 54 | |
| 13 | 2012 | 49 | |
| 14 | 2014 | 43 | |
| 15 | 2018 | 40 | |
| 16 | 2017 | 33 | |
| 17 | Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). | 1996 | 32 |
| 18 | 1996 | 31 | |
| 19 | 1996 | 24 | |
| 20 | 2023 | 23 |
About Amy Turner
Amy Turner is a scholar working on Molecular Biology, Pharmacology, Genetics, Oncology and Hematology, having authored 43 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (14 papers), Genomics and Rare Diseases (6 papers), Acute Myeloid Leukemia Research (4 papers), Pharmaceutical studies and practices (4 papers), RNA Research and Splicing (4 papers), Retinoids in leukemia and cellular processes (4 papers), RNA modifications and cancer (4 papers) and Muscle Physiology and Disorders (4 papers). The work is most often cited by research in Pharmacology (341 citations), Molecular Biology (1.1k citations), Transplantation (27 citations), Cancer Research (148 citations) and Oncology (268 citations). Amy Turner has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include W. David Jarvis, Steven Grant, Rebecca S. Traylor, Lawrence F. Povirk, Ulrich Broeckel, Praful Aggarwal, Andrea Gaedigk, Kevin P. Campbell, George R. Pettit and David A. Gewirtz. Their work appears in journals such as Journal of Molecular Diagnostics, Clinical Pharmacology & Therapeutics, Journal of Neuroscience, Biochemical Pharmacology and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.